Adenosine A۱ Receptor Antagonist Up-regulates Casp۳ and Stimulates Apoptosis Rate in Breast Cancer Cell Line T۴۷D

سال انتشار: 1399
نوع سند: مقاله ژورنالی
زبان: انگلیسی
مشاهده: 555

فایل این مقاله در 7 صفحه با فرمت PDF قابل دریافت می باشد

این مقاله در بخشهای موضوعی زیر دسته بندی شده است:

استخراج به نرم افزارهای پژوهشی:

لینک ثابت به این مقاله:

شناسه ملی سند علمی:

JR_IEJM-9-1_005

تاریخ نمایه سازی: 23 دی 1399

چکیده مقاله:

Background: Adenosine receptor family, especially A۱ type is-overexpressed in breast-derived tumor cells and the P۵۳ gene is mutant in some of these cells while the casps gene is of wild type as well. The aim of this study was to evaluate the effect of the A۱ receptor function on cell programmed death or proliferation, as well as the relationship between this receptor stimulation/inhibition and caspase ۳ (casp۳) expression in T۴۷D cell line that has a mutant and non-functional P۵۳ gene. Materials and Methods: The expression of casps۳ was measured by real-time polymerase chain reaction and then flow cytometery and MTT assay were used to assess the apoptotic and proliferation cell rate after the treatment of T۴۷D cells with specific agonist N۶-cyclopentyladenosine (CPA) and antagonist ۱,۳-dipropyl-۸-cyclopentylxanthine (DPCPX) of this receptor ۲۴, ۴۸, and ۷۲ hours after treatment. Result: Our results indicated that DPCPX significantly induces apoptosis in T۴۷D cells and the rate of survival cell after the reduction of this treatment, especially ۷۲ hours after treatment. Finally, the expression of casp۳ was up-regulated by DPCPX treatment, especially in ۷۲ hours while CPA treatment had opposite results (P > ۰.۰۵). Conclusion: In general, DPCPX could up-regulate casp۳ gene expression and subsequently increase the apoptosis rate in T۴۷D cells with casp۳ expression without the P۵۳ gene interference. Therefore, adenosine A۱ receptor antagonists may be introduced as anti-cancer agents.

کلیدواژه ها:

نویسندگان

Mohammad Zamani Rarani

Department of Anatomical Sciences, Faculty of Medicine, Hormozgan University of Medical Sciences, Hormozgan, Iran- Molecular Medicine Research Center, Hormozgan Health Institute, Hormozgan University of Medical Sciences, Bandar Abbas, Iran

Fahimeh Zamani Rarani

Department of Anatomical Sciences, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran

Ali Valiani

Department of Anatomical Sciences, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran

Zeinolabedin Sharifian Dastjerdi

Department of Anatomical Sciences, Faculty of Medicine, Hormozgan University of Medical Sciences, Hormozgan, Iran- Molecular Medicine Research Center, Hormozgan Health Institute, Hormozgan University of Medical Sciences, Bandar Abbas, Iran

Elias Kargar Abargouei

Department of Anatomical Sciences, Faculty of Medicine, Hormozgan University of Medical Sciences, Hormozgan, Iran- Molecular Medicine Research Center, Hormozgan Health Institute, Hormozgan University of Medical Sciences, Bandar Abbas, Iran

Ebrahim Eftekhar

Department of Anatomical Sciences, Faculty of Medicine, Hormozgan University of Medical Sciences, Hormozgan, Iran